Zealand Pharma A/S (ZLDPF)
OTCMKTS · Delayed Price · Currency is USD
61.06
+2.66 (4.55%)
Jul 24, 2025, 11:24 AM EDT
Zealand Pharma Market Cap
Zealand Pharma has a market cap or net worth of $4.18 billion as of July 25, 2025. Its market cap has decreased by -57.14% in one year.
Market Cap
4.18B
Enterprise Value
2.90B
Revenue
8.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
$61.06
Market Cap Chart
Since November 24, 2010, Zealand Pharma's market cap has increased from 252.13M to 4.18B, an increase of 1,558.93%. That is a compound annual growth rate of 21.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2025 | 4.18B | -40.54% |
| Dec 30, 2024 | 7.03B | 117.75% |
| Dec 29, 2023 | 3.23B | 116.91% |
| Dec 30, 2022 | 1.49B | 55.96% |
| Dec 30, 2021 | 954.96M | -34.02% |
| Dec 30, 2020 | 1.45B | 13.77% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.60B |
| Veradigm | 789.71M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 588.81M |
| Glass House Brands | 411.26M |
| Northwest Biotherapeutics | 382.85M |
| CytoDyn | 376.49M |